References
- Ulbricht C, Chao W, Costa D, Rusie-Seamon E, Weissner W, Woods J. Clinical evidence of herb–drug interactions: a systematic review by the natural standard research collaboration. Curr Drug Metab 2008;9:1063–1120
- Panay N, Rees M. Alternatives to HRT for the management of symptoms of the menopause. RCOG Scientific Advisory Committee Opinion Paper no 6; 2006 (2010 revision in press)
- Guideline on the use of the CTD format in the preparation of a registration application for traditional herbal medicinal products. http://www.ema.europa.eu/htms/human/hmpc/hmpcguide.htm
- Somjen D, Katzburg S, Livne E, Yoles I. DT56a (Femarelle) stimulates bone formation in female rats. BJOG 2005;112:981–985
- Powles TJ, Howell A, Evans DG, et al Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer. Menopause Int 2008;14:6–12
- PHYTOS: http://ec.europa.eu/research/endocrine/pdf/qlk1-ct2000-00431-year1.pdf
- PHYTOPREVENT: The role of dietary phytoestrogens in the prevention of breast and prostate cancer. http://www.ist-world.org/ProjectDetails.aspx?ProjectId=2f26ce134aca48e78b08fbfc9c8e2cbd
- Nachtigall LE, Baber RJ, Barentsen R, et al Complementary and hormonal therapy for vasomotor symptom relief: a conservative clinical approach. J Obstet Gynaecol Can 2006;28:279–289